The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pain Management Market Research Report 2025
Synopsis
Pain Management could help people release pain or make them feel less painful. These drug function on phsical or mental.
The global Pain Management market was valued at US$ 3213.5 million in 2023 and is anticipated to reach US$ 4484.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Pain Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pain Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pain Management in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pain Management include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management.
Report Scope
The Pain Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pain Management could help people release pain or make them feel less painful. These drug function on phsical or mental.
The global Pain Management market was valued at US$ 3213.5 million in 2023 and is anticipated to reach US$ 4484.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Pain Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pain Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pain Management in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pain Management include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management.
Report Scope
The Pain Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pain Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Management Market Perspective (2019-2030)
2.2 Pain Management Growth Trends by Region
2.2.1 Global Pain Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pain Management Historic Market Size by Region (2019-2024)
2.2.3 Pain Management Forecasted Market Size by Region (2025-2030)
2.3 Pain Management Market Dynamics
2.3.1 Pain Management Industry Trends
2.3.2 Pain Management Market Drivers
2.3.3 Pain Management Market Challenges
2.3.4 Pain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Management Players by Revenue
3.1.1 Global Top Pain Management Players by Revenue (2019-2024)
3.1.2 Global Pain Management Revenue Market Share by Players (2019-2024)
3.2 Global Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Management Revenue
3.4 Global Pain Management Market Concentration Ratio
3.4.1 Global Pain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Management Revenue in 2023
3.5 Pain Management Key Players Head office and Area Served
3.6 Key Players Pain Management Product Solution and Service
3.7 Date of Enter into Pain Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Management Breakdown Data by Type
4.1 Global Pain Management Historic Market Size by Type (2019-2024)
4.2 Global Pain Management Forecasted Market Size by Type (2025-2030)
5 Pain Management Breakdown Data by Application
5.1 Global Pain Management Historic Market Size by Application (2019-2024)
5.2 Global Pain Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pain Management Market Size (2019-2030)
6.2 North America Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pain Management Market Size by Country (2019-2024)
6.4 North America Pain Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Management Market Size (2019-2030)
7.2 Europe Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pain Management Market Size by Country (2019-2024)
7.4 Europe Pain Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Market Size (2019-2030)
8.2 Asia-Pacific Pain Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pain Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Pain Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pain Management Market Size (2019-2030)
9.2 Latin America Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pain Management Market Size by Country (2019-2024)
9.4 Latin America Pain Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Market Size (2019-2030)
10.2 Middle East & Africa Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pain Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Pain Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pain Management Introduction
11.1.4 Pfizer Revenue in Pain Management Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Pain Management Introduction
11.2.4 GSK Revenue in Pain Management Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Management Introduction
11.3.4 Grunenthal Revenue in Pain Management Business (2019-2024)
11.3.5 Grunenthal Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pain Management Introduction
11.4.4 Bayer Revenue in Pain Management Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pain Management Introduction
11.5.4 Sanofi Revenue in Pain Management Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pain Management Introduction
11.6.4 Eli Lilly Revenue in Pain Management Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pain Management Introduction
11.7.4 AstraZeneca Revenue in Pain Management Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Pain Management Introduction
11.8.4 Endo Revenue in Pain Management Business (2019-2024)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Pain Management Introduction
11.9.4 Merck Revenue in Pain Management Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Depomed
11.10.1 Depomed Company Detail
11.10.2 Depomed Business Overview
11.10.3 Depomed Pain Management Introduction
11.10.4 Depomed Revenue in Pain Management Business (2019-2024)
11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Detail
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao Pain Management Introduction
11.11.4 Yunnan Baiyao Revenue in Pain Management Business (2019-2024)
11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Pain Management Introduction
11.12.4 Teva Revenue in Pain Management Business (2019-2024)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Pain Management Introduction
11.13.4 J&J Revenue in Pain Management Business (2019-2024)
11.13.5 J&J Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Pain Management Introduction
11.14.4 Allergan Revenue in Pain Management Business (2019-2024)
11.14.5 Allergan Recent Development
11.15 Purdue
11.15.1 Purdue Company Detail
11.15.2 Purdue Business Overview
11.15.3 Purdue Pain Management Introduction
11.15.4 Purdue Revenue in Pain Management Business (2019-2024)
11.15.5 Purdue Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
